204 related articles for article (PubMed ID: 36726161)
21. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
[TBL] [Abstract][Full Text] [Related]
22. Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency.
Polai Z; Balla Z; Varga L; Benedek S; Farkas H
Heliyon; 2022 Nov; 8(11):e11292. PubMed ID: 36387475
[TBL] [Abstract][Full Text] [Related]
23. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
24. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
25. Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series.
Baeza ML; González-Quevedo T; Caballero T; Guilarte M; Lleonart R; Varela S; Castro M; Díaz C; Escudero E; García MG; Laffond E; Muñoz-Bellido FJ; Núñez R; Prior N; Sala-Cunill A; Sáenz de San Pedro B; Prieto-García A
J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1020-1028. PubMed ID: 34844023
[TBL] [Abstract][Full Text] [Related]
26. C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema.
Chevailler A; Arlaud G; Ponard D; Pernollet M; Carrère F; Renier G; Drouet M; Hurez D; Gardais J
J Allergy Clin Immunol; 1996 Apr; 97(4):998-1008. PubMed ID: 8655897
[TBL] [Abstract][Full Text] [Related]
27. Hereditary and acquired angioedema.
Patel G; Pongracic JA
Allergy Asthma Proc; 2019 Nov; 40(6):441-445. PubMed ID: 31690390
[TBL] [Abstract][Full Text] [Related]
28. Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies.
Jesenak M; Brndiarova M; Banovcin P; Varga L; Farkas H
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):255-256. PubMed ID: 32732186
[No Abstract] [Full Text] [Related]
29. Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.
Ponce IM; Caballero T; Reche M; Piteiro AB; López-Serrano MC; Fontán G; López-Trascasa M
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):632-7. PubMed ID: 12086372
[TBL] [Abstract][Full Text] [Related]
30. Chapter 22: Hereditary and acquired angioedema.
Georgy MS; Pongracic JA
Allergy Asthma Proc; 2012; 33 Suppl 1():73-76. PubMed ID: 22794695
[TBL] [Abstract][Full Text] [Related]
31. "Nuts and Bolts" of Laboratory Evaluation of Angioedema.
Farkas H; Veszeli N; Kajdácsi E; Cervenak L; Varga L
Clin Rev Allergy Immunol; 2016 Oct; 51(2):140-51. PubMed ID: 27142368
[TBL] [Abstract][Full Text] [Related]
32. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
Castelli R; Zanichelli A; Cicardi M; Cugno M
Crit Rev Oncol Hematol; 2013 Sep; 87(3):323-32. PubMed ID: 23490322
[TBL] [Abstract][Full Text] [Related]
33. Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.
Triggianese P; Guarino MD; Pellicano C; Borzi M; Greco E; Modica S; De Carolis C; Perricone R
Int Arch Allergy Immunol; 2017; 172(1):55-63. PubMed ID: 28222436
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G; Nguyen Y; Amarger S; Aubineau M; Bibes B; Blanchard-Delaunay C; Boccon-Gibod I; Bouillet L; Coppo P; Dalmas MC; Debord-Peguet S; Defendi F; Demoreuil C; Du-Thanh A; Gayet S; Hadjadj J; Jeandel PY; Launay D; Ly KH; Avoy CM; Niault M; Ollivier Y; Pelletier F; Porneuf M; Roos-Weil D; Fain O; Gobert D
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):212-222. PubMed ID: 37844846
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune C1 inhibitor deficiency: report of eight patients.
Cicardi M; Bisiani G; Cugno M; Späth P; Agostoni A
Am J Med; 1993 Aug; 95(2):169-75. PubMed ID: 8356982
[TBL] [Abstract][Full Text] [Related]
36. Quantification of human C1 esterase inhibitor protein using an automated turbidimetric immunoassay.
Tange CE; Kaur A; Verma N; Hickey A; Grigoriadou S; Scott C; Kiani S; Steven R; Ponsford M; El-Shanawany T; Jolles S; Harding S; Parker AR
J Clin Lab Anal; 2019 Jan; 33(1):e22627. PubMed ID: 30058083
[TBL] [Abstract][Full Text] [Related]
37. The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema.
Cicardi M; Zanichelli A
Curr Mol Med; 2010 Jun; 10(4):354-60. PubMed ID: 20455857
[TBL] [Abstract][Full Text] [Related]
38. Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.
Sbattella M; Zanichelli A; Ghia P; Gattei V; Suffritti C; Teatini T; Cicardi M; Castelli R
Med Oncol; 2018 Aug; 35(9):118. PubMed ID: 30073422
[TBL] [Abstract][Full Text] [Related]
39. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema.
Li HH; Busse P; Lumry WR; Frazer-Abel A; Levy H; Steele T; Dayno J; Riedl M
J Allergy Clin Immunol Pract; 2015; 3(2):200-5. PubMed ID: 25609336
[TBL] [Abstract][Full Text] [Related]
40. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
